mechanism and application to therapy in ALS, lethal irradiation, Alzheimer’s disease, stroke and myocardial infarction.
In preparation for publication in collaboration with Dr. Johannes Herkel. The peptide is being developed for clinical applications by the Israeli company Immune Pharma Limited (Eran Ovadia, CEO).